Home
About
Overview
Sharing Data
ORCID
Help
History (11)
Emerging biomarkers and molecular targets for precision medicine in cervical cancer.
Concurrent EGFR Mutation and ALK Translocation in Non-Small Cell Lung Cancer.
A phase I dose-escalating study of combination pemetrexed-based chemotherapy and concomitant radiotherapy for locally advanced or metastatic non-small cell lung or esophageal cancer.
Overcoming Barriers to Tobacco Cessation and Lung Cancer Screening among Racial and Ethnic Minority Groups and Underserved Patients in Academic Centers and Community Network Sites: The City of Hope Experience.
ROS1 rearranged non-small cell lung cancer brain metastases respond to low dose radiotherapy.
See All 11 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
ROS1 rearranged non-small cell lung cancer brain metastases respond to low dose radiotherapy.
ROS1 rearranged non-small cell lung cancer brain metastases respond to low dose radiotherapy. J Clin Neurosci. 2015 Dec; 22(12):1978-9.
View in:
PubMed
subject areas
Adult
Brain Neoplasms
Carcinoma, Non-Small-Cell Lung
Female
Gene Rearrangement
Humans
Lung Neoplasms
Protein-Tyrosine Kinases
Proto-Oncogene Proteins
authors with profiles
Martin Nicholas
Ravi Salgia
Yasmin Hasan